Geremia B Bolli

Summary

Affiliation: University of Perugia
Country: Italy

Publications

  1. ncbi Optimizing the replacement of basal insulin in type 1 diabetes mellitus: no longer an elusive goal in the post-NPH era
    Geremia B Bolli
    Section of Internal Medicine, Endocrinology and Metabolism, Department of Internal Medicine, University of Perugia, Perugia, Italy
    Diabetes Technol Ther 13:S43-52. 2011
  2. ncbi Type 1 diabetes mellitus: effective insulin strategies with less hypoglycemia
    Geremia B Bolli
    Sezione di Medicina Interna, Universita di Perugia, 06126 Perugia, Italy
    Postgrad Med 116:13-20. 2004
  3. ncbi Effect of oral amino acids on counterregulatory responses and cognitive function during insulin-induced hypoglycemia in nondiabetic and type 1 diabetic people
    Paolo Rossetti
    Department of Internal Medicine, University of Perugia, Perugia, Italy
    Diabetes 57:1905-17. 2008
  4. ncbi Mechanisms of insulin resistance after insulin-induced hypoglycemia in humans: the role of lipolysis
    Paola Lucidi
    Department of Internal Medicine, Section of Internal Medicine, Endocrinology and Metabolism, University of Perugia, Perugia, Italy
    Diabetes 59:1349-57. 2010
  5. ncbi Portal vein glucose sensors do not play a major role in modulating physiological responses to insulin-induced hypoglycemia in humans
    Paolo Rossetti
    Department of Internal Medicine, University of Perugia, Perugia, Italy
    Diabetes 58:194-202. 2009
  6. ncbi Metabolic and endocrine effects of physiological increments in plasma ghrelin concentrations
    Paola Lucidi
    Department of Internal Medicine, Section of Internal Medicine and Endocrine and Metabolic Sciences (I.M.I.S.E.M, University of Perugia, Via Enrico Dal Pozzo, 06126 Perugia, Italy
    Nutr Metab Cardiovasc Dis 15:410-7. 2005
  7. ncbi Insulin is required for prandial ghrelin suppression in humans
    Giuseppe Murdolo
    Department of Internal Medicine, Section of Internal Medicine and Endocrine and Metabolic Sciences IMISEM, University of Perugia, Perugia, Italy
    Diabetes 52:2923-7. 2003
  8. ncbi Differential effects of adiposity on pharmacodynamics of basal insulins NPH, glargine, and detemir in type 2 diabetes mellitus
    Francesca Porcellati
    Department of Internal Medicine, Section of Internal Medicine, Endocrinology and Metabolism, University of Perugia, Perugia, Italy
    Diabetes Care 34:2521-3. 2011
  9. ncbi Pharmacokinetics and pharmacodynamics of therapeutic doses of basal insulins NPH, glargine, and detemir after 1 week of daily administration at bedtime in type 2 diabetic subjects: a randomized cross-over study
    Paola Lucidi
    Department of Internal Medicine, Section of Internal Medicine, Endocrinology and Metabolism, University of Perugia, Perugia, Italy
    Diabetes Care 34:1312-4. 2011
  10. ncbi Comparison of pharmacokinetics and dynamics of the long-acting insulin analogs glargine and detemir at steady state in type 1 diabetes: a double-blind, randomized, crossover study
    Francesca Porcellati
    Department of Internal Medicine, Section of Internal Medicine, Endocrinology and Metabolism, University of Perugia, Via E dal Pozzo, 06126 Perugia, Italy
    Diabetes Care 30:2447-52. 2007

Collaborators

Detail Information

Publications31

  1. ncbi Optimizing the replacement of basal insulin in type 1 diabetes mellitus: no longer an elusive goal in the post-NPH era
    Geremia B Bolli
    Section of Internal Medicine, Endocrinology and Metabolism, Department of Internal Medicine, University of Perugia, Perugia, Italy
    Diabetes Technol Ther 13:S43-52. 2011
    ....
  2. ncbi Type 1 diabetes mellitus: effective insulin strategies with less hypoglycemia
    Geremia B Bolli
    Sezione di Medicina Interna, Universita di Perugia, 06126 Perugia, Italy
    Postgrad Med 116:13-20. 2004
    ..Insulin glargine reduces the frequency of nocturnal hypoglycemia compared with NPH when used with rapid-acting analogues and thus facilitates optimal insulin replacement therapy...
  3. ncbi Effect of oral amino acids on counterregulatory responses and cognitive function during insulin-induced hypoglycemia in nondiabetic and type 1 diabetic people
    Paolo Rossetti
    Department of Internal Medicine, University of Perugia, Perugia, Italy
    Diabetes 57:1905-17. 2008
    ..The aim of this study was to assess the responses to hypoglycemia in nondiabetic and type 1 diabetic subjects after ingestion of an amino acid mixture...
  4. ncbi Mechanisms of insulin resistance after insulin-induced hypoglycemia in humans: the role of lipolysis
    Paola Lucidi
    Department of Internal Medicine, Section of Internal Medicine, Endocrinology and Metabolism, University of Perugia, Perugia, Italy
    Diabetes 59:1349-57. 2010
    ..However, it is not known whether FFA plays a role in the development of posthypoglycemic insulin resistance as well...
  5. ncbi Portal vein glucose sensors do not play a major role in modulating physiological responses to insulin-induced hypoglycemia in humans
    Paolo Rossetti
    Department of Internal Medicine, University of Perugia, Perugia, Italy
    Diabetes 58:194-202. 2009
    ..The aim of the present study was to examine in humans the potential role of portal vein glucose sensors in physiological responses to insulin-induced hypoglycemia mimicking the slow fall of insulin-treated diabetic subjects...
  6. ncbi Metabolic and endocrine effects of physiological increments in plasma ghrelin concentrations
    Paola Lucidi
    Department of Internal Medicine, Section of Internal Medicine and Endocrine and Metabolic Sciences (I.M.I.S.E.M, University of Perugia, Via Enrico Dal Pozzo, 06126 Perugia, Italy
    Nutr Metab Cardiovasc Dis 15:410-7. 2005
    ....
  7. ncbi Insulin is required for prandial ghrelin suppression in humans
    Giuseppe Murdolo
    Department of Internal Medicine, Section of Internal Medicine and Endocrine and Metabolic Sciences IMISEM, University of Perugia, Perugia, Italy
    Diabetes 52:2923-7. 2003
    ..lack of meal-induced ghrelin suppression caused by severe insulin deficiency may explain hyperphagia of uncontrolled type 1 diabetic subjects...
  8. ncbi Differential effects of adiposity on pharmacodynamics of basal insulins NPH, glargine, and detemir in type 2 diabetes mellitus
    Francesca Porcellati
    Department of Internal Medicine, Section of Internal Medicine, Endocrinology and Metabolism, University of Perugia, Perugia, Italy
    Diabetes Care 34:2521-3. 2011
    ....
  9. ncbi Pharmacokinetics and pharmacodynamics of therapeutic doses of basal insulins NPH, glargine, and detemir after 1 week of daily administration at bedtime in type 2 diabetic subjects: a randomized cross-over study
    Paola Lucidi
    Department of Internal Medicine, Section of Internal Medicine, Endocrinology and Metabolism, University of Perugia, Perugia, Italy
    Diabetes Care 34:1312-4. 2011
    ..To compare the pharmacokinetics and pharmacodynamics of NPH, glargine, and detemir insulins in type 2 diabetic subjects...
  10. ncbi Comparison of pharmacokinetics and dynamics of the long-acting insulin analogs glargine and detemir at steady state in type 1 diabetes: a double-blind, randomized, crossover study
    Francesca Porcellati
    Department of Internal Medicine, Section of Internal Medicine, Endocrinology and Metabolism, University of Perugia, Via E dal Pozzo, 06126 Perugia, Italy
    Diabetes Care 30:2447-52. 2007
    ..4 +/- 1.6 kg/m2, and A1C 7.2 +/- 0.7%) were studied after a 2-week treatment with either glargine or detemir once daily (randomized, double-blind, crossover study)...
  11. ncbi Pharmacokinetics and pharmacodynamics of the long-acting insulin analog glargine after 1 week of use compared with its first administration in subjects with type 1 diabetes
    Francesca Porcellati
    University of Perugia, Department of Internal Medicine, Section of Internal Medicine, Endocrinology, and Metabolism, Via E. Dal Pozzo, 06126 Perugia, Italy
    Diabetes Care 30:1261-3. 2007
  12. ncbi Comparison of a multiple daily insulin injection regimen (basal once-daily glargine plus mealtime lispro) and continuous subcutaneous insulin infusion (lispro) in type 1 diabetes: a randomized open parallel multicenter study
    Geremia B Bolli
    Department of Internal Medicine, University of Perugia, Perugia, Italy
    Diabetes Care 32:1170-6. 2009
    ..We aimed to help close that deficiency...
  13. ncbi Short-term effects of the long-acting insulin analog detemir and human insulin on plasma levels of insulin-like growth factor-I and its binding proteins in humans
    Francesca Porcellati
    University of Perugia, Department of Internal Medicine, Via E dal Pozzo, Perugia, Italy
    J Clin Endocrinol Metab 94:3017-24. 2009
    ....
  14. ncbi Intensive replacement of basal insulin in patients with type 1 diabetes given rapid-acting insulin analog at mealtime: a 3-month comparison between administration of NPH insulin four times daily and glargine insulin at dinner or bedtime
    Paolo Rossetti
    Section of Internal Medicine, Endocrinology and Metabolism, University of Perugia, Italy
    Diabetes Care 26:1490-6. 2003
    ..In contrast to NPH, which should be given at bedtime, insulin glargine can be administered at dinnertime without deteriorating blood glucose control...
  15. ncbi Prevention of hypoglycemia while achieving good glycemic control in type 1 diabetes: the role of insulin analogs
    Paolo Rossetti
    Department of Internal Medicine, University of Perugia, Perugia, Italy
    Diabetes Care 31:S113-20. 2008
  16. ncbi Counterregulatory hormone and symptom responses to insulin-induced hypoglycemia in the postprandial state in humans
    Francesca Porcellati
    Section of Internal Medicine, University of Perugia, Perugia, Italy
    Diabetes 52:2774-83. 2003
    ..In conclusion, in the postprandial compared with the fasting hypoglycemic state, total symptoms are less, but counterregulatory hormones are greater and responses of glucagon nearly normalize in type 1 diabetic subjects...
  17. ncbi Different brain responses to hypoglycemia induced by equipotent doses of the long-acting insulin analog detemir and human regular insulin in humans
    Paolo Rossetti
    Department of Internal Medicine, Endocrinology, and Metabolism, University of Perugia, Via E dal Pozzo, 06126 Perugia, Italy
    Diabetes 57:746-56. 2008
    ..The aim of these studies was to assess the brain/hypothalamus responses to euglycemia and hypoglycemia in humans during intravenous infusion of equipotent doses of detemir and human insulin...
  18. ncbi Insulin therapy and hypoglycaemia: the size of the problem
    Carmine G Fanelli
    Section of Internal Medicine, University of Perugia, Italy
    Diabetes Metab Res Rev 20:S32-42. 2004
    ..Finally, hypoglycaemia may be fatal. Hypoglycaemia induced by insulin as treatment of type 1 diabetes mellitus (T1 DM) is not the consequence of diabetes, but invariably of the non-physiological replacement of insulin...
  19. ncbi Metabolism of insulin glargine after repeated daily subcutaneous injections in subjects with type 2 diabetes
    Paola Lucidi
    Internal Medicine, University of Perugia, Perugia, Italy
    Diabetes Care 35:2647-9. 2012
    ..To investigate concentration of plasma insulin glargine after its subcutaneous dosing compared with concentration of its metabolites 1 (M1) and 2 (M2) in subjects with type 2 diabetes...
  20. ncbi Superiority of insulin analogues versus human insulin in the treatment of diabetes mellitus
    Paolo Rossetti
    Department of Internal Medicine, Endocrinology and Metabolism, University of Perugia, Via E dal Pozzo, Perugia, Italy
    Arch Physiol Biochem 114:3-10. 2008
    ..Rapid- and long-acting insulin analogues should always be combined in the treatment of T1 and T2DM...
  21. ncbi Ghrelin is not necessary for adequate hormonal counterregulation of insulin-induced hypoglycemia
    Paola Lucidi
    Department of Internal Medicine, Section Internal Medicine, Endocrine and Metabolic Sciences, University of Perugia, Italy
    Diabetes 51:2911-4. 2002
    ..These results raise the possibility that postprandial hyperinsulinemia is responsible for the reduction of plasma ghrelin that occurs during meal intake...
  22. ncbi Hyperglycemia-induced platelet activation in type 2 diabetes is resistant to aspirin but not to a nitric oxide-donating agent
    Paolo Gresele
    Section of Internal and Cardiovascular Medicine, Department of Internal Medicine, University of Perugia, Perugia, Italy
    Diabetes Care 33:1262-8. 2010
    ..Our aim was to assess comparatively the effect of aspirin, a nitric oxide-donating agent (NCX 4016), their combination, or placebo on platelet activation induced by acute hyperglycemia in type 2 diabetes...
  23. ncbi Insulin treatment in type 1 diabetes
    Geremia B Bolli
    Department of Medicine, University of Perugia, Italy
    Endocr Pract 12:105-9. 2006
    ..Clinicians should prescribe insulin regimens that yield physiologic results in patients with type 1 diabetes...
  24. ncbi Pharmacokinetics and pharmacodynamics of basal insulins
    Francesca Porcellati
    Department of Internal Medicine, University of Perugia, Perugia, Italy
    Diabetes Technol Ther 13:S15-24. 2011
    ..These differences should be taken into consideration when the individual analogs are introduced to provide basal insulin supplementation to optimize blood glucose control in patients with type 1 and type 2 diabetes as well...
  25. ncbi Long-term intervention studies using insulin in patients with type 1 diabetes
    Geremia B Bolli
    Department of Medicine, University of Perugia, Italy
    Endocr Pract 12:80-4. 2006
    ..Therefore, safe achievement and maintenance of target glycemic goals are possible...
  26. ncbi Treatment and prevention of hypoglycemia and its unawareness in type 1 diabetes mellitus
    Geremia B Bolli
    Department of Internal Medicine, University of Perugia, Italy
    Rev Endocr Metab Disord 4:335-41. 2003
  27. ncbi International Forum for the Advancement of Diabetes Research and Care, April 29-30, 2011, Athens, Greece
    Geremia B Bolli
    Department of Medicine, University of Perugia, Perugia, Italy
    Diabetes Technol Ther 13:967-79. 2011
    ..The meeting represented an excellent forum for the presentation of new research and the exchange of ideas aimed at improving outcomes for people with diabetes...
  28. ncbi Administration of neutral protamine Hagedorn insulin at bedtime versus with dinner in type 1 diabetes mellitus to avoid nocturnal hypoglycemia and improve control. A randomized, controlled trial
    Carmine G Fanelli
    Department of Internal Medicine, University of Perugia, Via E. Dal Pozzo, I-06126 Perugia, Italy
    Ann Intern Med 136:504-14. 2002
    ....
  29. ncbi Rational use of insulin analogues in the treatment of type 1 diabetes mellitus
    Geremia B Bolli
    University of Perugia, Section of Internal Medicine, Endocrinology and Metabolism, Perugia, Italy
    Pediatr Endocrinol Rev 1:9-21. 2003
    ..As compared to NPH, glargine reduces the risk for nocturnal hypoglycaemia, and at the same time improves HbA1c similarly to CSII...
  30. ncbi Acute, short-term hyperglycemia enhances shear stress-induced platelet activation in patients with type II diabetes mellitus
    Paolo Gresele
    Division of Internal and Cardiovascular Medicine, Department of Internal Medicine, University of Perugia, Via E dal Pozzo, snc 06126, Perugia, Italy
    J Am Coll Cardiol 41:1013-20. 2003
    ..The aim of our study was to assess whether acute, short-term hyperglycemia affects platelet reactivity in patients with Type II diabetes mellitus (T2DM)...
  31. ncbi Plasma exposure to insulin glargine and its metabolites M1 and M2 after subcutaneous injection of therapeutic and supratherapeutic doses of glargine in subjects with type 1 diabetes
    Geremia B Bolli
    Department of Internal Medicine, University of Perugia, Perugia, Italy
    Diabetes Care 35:2626-30. 2012
    ..The aim of the study was to quantitate plasma concentrations of glargine, M1, and M2 after subcutaneous injection of glargine in male type 1 diabetic subjects...